Search

everythinglearnresearchcommunity

for

Search:↓

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

Radiofrequency exposure can stimulate hair growth by increasing IGF-1 in hair follicle cells.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Hormones significantly affect hair growth and loss, with potential for new treatments.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The effects of estrogen on human scalp hair growth are unclear and need more research.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.